Free Newsletter
New Jersey loses 800 pharma jobs
Schering-Plough will cut a minimum of 500 jobs starting on August 11th in New Jersey as part of a much larger plan to layoff 5,500 employees across the globe. At the same time, Johnson & Johnson will send about the same number of employees packing when it cuts nearly 300 jobs nationwide and shifts 260 positions out of New Jersey.
The Schering-Plough layoffs will be mainly be at its Kenilworth facility, but will also affect facilities in Berkeley Heights, Roseland, Springfield, Summit and Union. The shifted J&J positions will move to Pennsylvania and will become part of the company's Centocor subsidiary following a merger of the unit with its Ortho-Biotech unit.
Abbott Labs also announced it would move 83 positions in Parsippany to its research headquarters in Abbott Park, IL, also in August.
- read the full story at Newsday
- get the local news at NJ.com
- here's more at the Pharmalot blog
Related Articles:
NJ will feel brunt of Schering axe
Top 8 layoffs of 2007
Fortune snubs Big Pharma in employers list
NJ officials want to expand biopharma biz
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: